Home  |  About MEFS  |  Annual Meeting  |  Membership  |  Specialty Groups  | News & Publications  |  Education |  Calendar  | Links

 
 

MEFS Exchange course & Symposium- ASRM2012

PG12: Assisted Reproduction: Maximizing Success And Avoiding Risks

 

Date: October 21, 2012

Time: 8:15 am - 5:00 pm

Location: Room 7 - San Diego Convention Center

Presenters

Hassan N. Sallam, M.D., Ph.D. (Chair), Alexandria University

Botros Rizk, M.D. (Co-Chair), University of South Alabama

G. David Adamson, M.D., Fertility Physicians of Northern California

David R. Meldrum, M.D., Reproductive Partners Medical Group, Inc.

Supporters

Developed in Cooperation with the Middle East Fertility Society

ACGME Competency
Patient Care
 

NEEDS ASSESSMENT AND COURSE DESCRIPTION
Responses to test questions in 2009 and 2010 revealed stark differences among physicians in the selection of the most appropriate gonadotropin stimulation regimen to achieve high live birth rates in assisted reproduction. It was evident that many clinicians do not follow evidence-based protocols for ovarian stimulation in obese patients or patients with endometriosis, polycystic ovary syndrome or other diseases of the reproductive system. The goal of this course is to teach clinicians, scientists and nurses working in the field of assisted reproduction how to identify patients who are likely to benefit from assisted reproductive technologies, the criteria for selecting a stimulation regimen, and procedures to optimize the chances of achieving live births. Issues related to obesity, endometriosis, ovarian stimulation, embryo transfer, the role of the endometrium and repeated implantation failure will be discussed.

LEARNING OBJECTIVES
At the conclusion of this course, participants should be able to:

1.     Select the most appropriate regimen for ovarian stimulation that will yield optimal oocytes but not cause ovarian hyperstimulation syndrome.

2.     Balance the benefits of achieving pregnancy with the risks of complications in patients undergoing in vitro fertilization with intracytoplasmic sperm injection.

3.     Treat infertility in patients suffering from obesity, polycystic ovary syndrome, endometriosis and repeated implantation failure.